America’s biopharmaceutical research companies are developing 1,100 medicines and vaccines for cancer.
in cancer are attributable to new medicines
Americans are cancer survivors as of January 2016
in the cancer death rate since peaking in the 1990s
are expected in 2018
estimated new cases of cancer in 2018 in the U.S.